Alumni Ventures
Alumni Ventures Group, LLC is a venture capital firm founded in 2013 and based in Manchester, New Hampshire, with additional offices in North America. The firm specializes in seed, early-stage, and late-stage pre-IPO investments, focusing on companies that have an alumni connection and an institutional lead investor with relevant expertise. It offers high-quality, diversified venture portfolios to individual investors, particularly accredited alumni from top entrepreneurial schools, who previously lacked access to venture capital opportunities. Alumni Ventures Group invests between $0.01 million and $3 million in various sectors and geographies, without seeking board or observer seats. Additionally, the firm provides focused funds that enable any accredited investor to access a diverse venture portfolio, allowing for investment across different types, sectors, stages, and geographical locations.
Americana is an NFT marketplace where physical items can be bought and sold. The company was founded in 2021 and is headquartered in Baltimore, Maryland. The United States
ION Storage Systems, LLC is a manufacturer of solid state lithium-ion batteries, headquartered in College Park, Maryland. Established in 2015, the company specializes in developing advanced battery technology aimed at delivering high energy density and enhanced safety for various applications. Its products cater to the defense and aerospace sectors, as well as the consumer electronics and electric vehicle industries. By focusing on solid state battery innovations, ION Storage Systems addresses the critical performance and safety requirements necessary for deployment in diverse environments.
Houwzer, LLC provides real estate brokerage services for buying and selling a home. It also provides industry insights for home buyers and sellers. In addition, it offers communication tools, featured listings, total transaction management, social and email marketing, and direct mail campaign services. The company was incorporated in 2014 and is based in Philadelphia, Pennsylvania with additional offices in Washington, District of Columbia; Baltimore, Maryland; and Haddonfield, New Jersey.
X-energy is delivering the next generation of carbon-free energy by reinventing nuclear power. X-energy manufactures fuel that seals uranium particles in a protective coating, which makes meltdown impossible and retains the waste inside forever. We also design plants that unlock the fuel’s potential in a process that’s as clean as wind or solar. When combined, the result is reliable carbon-free baseload power, produced more safely and affordable than ever before and available anywhere, at any time.
miRecule, Inc. is a biotechnology company specializing in the development of microRNA-based therapeutics, with a focus on addressing challenges in cancer treatment and other diseases such as muscular dystrophy. Founded in 2016 and headquartered in Gaithersburg, Maryland, the company has created a drug discovery platform called DREAmiR. This platform leverages genomic and outcome data from thousands of patients to identify genetic changes linked to diseases. It combines genomic sequencing, expression, and prognostic data from cancer patients with high-throughput screening data to pinpoint microRNA candidates for replacement therapy. miRecule's approach aims to formulate these candidates into tumor-targeted nanoparticles, enabling oncologists to effectively target and eliminate drug-resistant cancer cells.
Houwzer, LLC provides real estate brokerage services for buying and selling a home. It also provides industry insights for home buyers and sellers. In addition, it offers communication tools, featured listings, total transaction management, social and email marketing, and direct mail campaign services. The company was incorporated in 2014 and is based in Philadelphia, Pennsylvania with additional offices in Washington, District of Columbia; Baltimore, Maryland; and Haddonfield, New Jersey.
Securrency, Inc. is a financial technology company that specializes in the tokenized issuance and trading of securities. Established in 2015 and based in Riva, Maryland, Securrency operates additional offices in Washington, D.C., New York City, and Abu Dhabi. The company’s platform integrates legacy financial services with modern distributed ledger technologies, allowing for efficient trading of illiquid asset classes. Its protocol supports various distributed ledgers, including Ethereum and Stellar, facilitating the seamless movement of tokens both on-chain and off-chain. By focusing on security and compliance, Securrency aims to enhance the transparency, efficiency, and accessibility of financial services, connecting investors seeking returns with asset owners, startups, and fund managers in need of capital.
Securrency, Inc. is a financial technology company that specializes in the tokenized issuance and trading of securities. Established in 2015 and based in Riva, Maryland, Securrency operates additional offices in Washington, D.C., New York City, and Abu Dhabi. The company’s platform integrates legacy financial services with modern distributed ledger technologies, allowing for efficient trading of illiquid asset classes. Its protocol supports various distributed ledgers, including Ethereum and Stellar, facilitating the seamless movement of tokens both on-chain and off-chain. By focusing on security and compliance, Securrency aims to enhance the transparency, efficiency, and accessibility of financial services, connecting investors seeking returns with asset owners, startups, and fund managers in need of capital.
miRecule, Inc. is a biotechnology company specializing in the development of microRNA-based therapeutics, with a focus on addressing challenges in cancer treatment and other diseases such as muscular dystrophy. Founded in 2016 and headquartered in Gaithersburg, Maryland, the company has created a drug discovery platform called DREAmiR. This platform leverages genomic and outcome data from thousands of patients to identify genetic changes linked to diseases. It combines genomic sequencing, expression, and prognostic data from cancer patients with high-throughput screening data to pinpoint microRNA candidates for replacement therapy. miRecule's approach aims to formulate these candidates into tumor-targeted nanoparticles, enabling oncologists to effectively target and eliminate drug-resistant cancer cells.
miRecule, Inc. is a biotechnology company specializing in the development of microRNA-based therapeutics, with a focus on addressing challenges in cancer treatment and other diseases such as muscular dystrophy. Founded in 2016 and headquartered in Gaithersburg, Maryland, the company has created a drug discovery platform called DREAmiR. This platform leverages genomic and outcome data from thousands of patients to identify genetic changes linked to diseases. It combines genomic sequencing, expression, and prognostic data from cancer patients with high-throughput screening data to pinpoint microRNA candidates for replacement therapy. miRecule's approach aims to formulate these candidates into tumor-targeted nanoparticles, enabling oncologists to effectively target and eliminate drug-resistant cancer cells.
TRM Labs is a regulatory technology startup that aims to streamline compliance in the crypto industry.They believe that blockchain can enable a world where value flows freely by democratizing the creation of property rights, reducing transaction, bargaining, and coordination costs, and enabling new ways to organize human behavior.
American Gene Technologies is a gene and cell therapeutics company based in Rockville, Maryland, founded in 2007. The company specializes in developing a proprietary lentiviral platform that enables the creation of bio-safe lentivirus therapies for a range of applications, including cancer, HIV/AIDS, and inherited disorders. Their developmental portfolio features advanced tools and components for gene therapy and regenerative medicine, with a focus on innovative treatments like AGT103-T, which aims to provide a functional cure for HIV. Additionally, American Gene Technologies is working on a synthetic gene designed to deliver therapeutic levels of phenylalanine hydroxylase for the treatment of Phenylketonuria (PKU). The company's mission is to harness gene and cell therapy to alleviate suffering from serious diseases.
Talk Local connects your business to consumers who are looking for your services! The consumer fills out a service request that includes a brief description, desired appointment time, and where they are located. Talk Local then broadcasts the consumer’s service request to you for free.
Talk Local connects your business to consumers who are looking for your services! The consumer fills out a service request that includes a brief description, desired appointment time, and where they are located. Talk Local then broadcasts the consumer’s service request to you for free.